Olink Reveal ― Midplex proteomics that accelerates clinical and drug discovery research Campaign ongoing until orders received by August 28, 2026 (Friday). 1. 15% off when purchasing 4 Olink Reveal kits 2. 10% off for new users of Olink Reveal on 1 kit Olink Reveal is a midplex solution that connects Explore HT (exploration) and Target (target). It features approximately 1,000 carefully selected proteins that are important for disease research, focusing on immune and inflammation-related markers, as well as cancer, cardiovascular diseases, neurological disorders, and infectious diseases. It includes numerous Druggable Targets directly related to clinical research and drug development, addressing a wide range of research needs from biomarker discovery to target identification and patient stratification. It is rich in over 700 proteins with genetic evidence based on cis-pQTL data obtained from the UK Biobank Pharma Proteomics Project (UKB-PPP), strongly supporting causal inference and target validity assessment.